Management of Hypertension and Tachycardia in Pregnancy

Introduction to Guidelines

The European Society of Cardiology recommends initiating labetalol as first-line therapy for pregnant women with hypertension and tachycardia when blood pressure reaches ≥140/90 mmHg, targeting BP below 140/90 mmHg but maintaining diastolic BP above 80 mmHg to preserve uteroplacental perfusion 1, 2, 3

The European Society of Cardiology recommends starting pharmacological treatment at BP ≥140/90 mmHg for both chronic and gestational hypertension in pregnancy 1, 2
The target BP should be below 140/90 mmHg but not below 80 mmHg diastolic to reduce maternal risk while maintaining adequate placental blood flow 1, 2, 3
The American Diabetes Association supports targeting diastolic BP of 85 mmHg based on the CHIPS trial, which showed reduced maternal accelerated hypertension without adverse fetal outcomes when achieving mean systolic BP of 133 mmHg and diastolic of 85 mmHg 4

Labetalol is the optimal choice when both hypertension and tachycardia are present, as it provides dual alpha- and beta-blocking effects that control both conditions simultaneously 1, 2, 3
Methyldopa is preferred based on long-term safety data, though it does not address tachycardia 5, 6, 2

Extended-release nifedipine is effective for BP control but may worsen tachycardia through reflex sympathetic activation 1, 2

ACE inhibitors, ARBs, and direct renin inhibitors are strictly contraindicated due to severe fetotoxicity, particularly in second and third trimesters 4, 1, 2, 7, 3
Atenolol should be avoided as it is specifically contraindicated in pregnancy due to associations with intrauterine growth retardation 6, 3

Beta-1 selective beta-blockers are first choice for tachycardia prophylaxis in pregnancy, with labetalol being ideal as it simultaneously treats hypertension 8
For acute supraventricular tachycardia episodes, vagal maneuvers followed by intravenous adenosine should be attempted first 8
Electrical cardioversion is not contraindicated and should be used for any sustained tachycardia causing hemodynamic instability that threatens fetal security 8

When BP reaches ≥160/110 mmHg, immediate hospitalization is required with urgent treatment to prevent maternal stroke and eclampsia 5
First-line acute treatment options include labetalol, hydralazine, and nifedipine 5

Weekly BP monitoring until stable on antihypertensive regimen, with assessment for preeclampsia symptoms at each visit 3
Urine protein assessment should be performed to evaluate for preeclampsia development 3

Women with Stage 1 hypertension without target organ damage may initially be managed with lifestyle modifications alone, as BP often falls during first half of pregnancy 5, 6
Treatment must be reinstituted when BP reaches 150-160/100-110 mmHg to prevent progression to severe hypertension 5, 6

Sodium restriction to 2.4 g/day is recommended, though normal diet without severe salt restriction is advised near delivery to maintain intravascular volume 5, 7
Aerobic exercise should be restricted based on theoretical concerns about inadequate placental blood flow 5
Weight reduction should not be attempted, even in obese pregnant women, as it can lead to reduced neonatal weight 5, 7
Low-dose aspirin should be started before 16 weeks gestation in women with history of early-onset preeclampsia 7

Monitor BP for 72 hours in hospital and 7-10 days postpartum as recommended by the American College of Cardiology 4, 3
Counsel on increased lifetime cardiovascular risk: women with gestational hypertension have 4-fold increased risk of future hypertension and 2-fold increased risk of ischemic heart disease 3
Annual cardiovascular risk assessment should be performed lifelong in women with history of hypertensive disorders of pregnancy 3

Do not aggressively lower BP below 80 mmHg diastolic, as meta-analysis of 45 trials showed direct linear relationship between treatment-induced fall in mean arterial pressure and proportion of small-for-gestational-age infants 5, 6
Do not continue ACE inhibitors or ARBs inadvertently discovered in early pregnancy—switch immediately to safe alternatives and arrange close fetal ultrasound monitoring 7
Do not use short-acting nifedipine, as it is not FDA-approved for hypertension management and can cause precipitous BP drops, especially with concurrent magnesium sulfate 5
Do not delay delivery in severe preeclampsia regardless of gestational age if there are signs of fetal distress, intrauterine growth retardation, or maternal complications (HELLP syndrome, pulmonary edema, visual disturbances) 5, 8